You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Intravesical administration

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Urinary Bladder Tumors Trial in Pittsburgh (Magnetic Resonance Imaging, Gadobutrol intravesical administration (4mM),

Recruiting
  • Urinary Bladder Neoplasms
  • Magnetic Resonance Imaging
  • +2 more
  • Pittsburgh, Pennsylvania
    UPMC Department of Urology
Jan 7, 2022

Bladder Cancer Trial in Athens (Durvalumab)

Active, not recruiting
  • Bladder Cancer
  • Durvalumab
  • Athens, Attica, Greece
    Hellenic GenitoUrinary Cancer Group
Mar 22, 2022

Superficial Bladder Cancer Trial in United States (EG-70)

Recruiting
  • Superficial Bladder Cancer
  • Tucson, Arizona
  • +7 more
May 11, 2022

Bladder Urothelial Carcinoma In Situ, Recurrent Bladder Urothelial Carcinoma, Stage 0a Bladder Cancer AJCC v8 Trial in Seattle

Recruiting
  • Bladder Urothelial Carcinoma In Situ
  • +5 more
  • Acupuncture Therapy
  • +4 more
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
May 27, 2022

Urinary Bladder Tumors, Immunotherapy Trial in Shanghai (Camrelizumab)

Recruiting
  • Urinary Bladder Neoplasms
  • Immunotherapy
  • Shanghai, Shanghai, China
  • +3 more
Oct 9, 2021

Bladder Cancer Trial (intravesical electromotive administration of mitomycin)

Completed
  • Bladder Cancer
  • intravesical electromotive administration of mitomycin
  • (no location specified)
Mar 15, 2020

Intravesical N-803 Plus BCG in BCG-Naive Non-Muscle Invasive

Recruiting
  • Non Muscle Invasive Bladder Cancer
  • N803 plus Bacillus Calmette-Guerin (BCG)
  • Honolulu, Hawaii
    Island Urology
Aug 7, 2023

High-risk Non-muscle Invasive Bladder Cancer Trial (SHR-2005)

Not yet recruiting
  • High-risk Non-muscle Invasive Bladder Cancer
  • (no location specified)
Oct 25, 2023

Lower Urinary Tract Symptoms, Intravenous Drug Usage, Bladder Cancer Trial in Taipei (JING SI HERBAL TEA, Placebo)

Enrolling by invitation
  • Lower Urinary Tract Symptoms
  • +3 more
  • JING SI HERBAL TEA
  • Placebo
  • Taipei, Taiwan
    Buddhist Tzu Chi General Hospital, Taipei branch
Feb 20, 2023

Urothelial Carcinoma Bladder, Sperm Count, Low, Testis; Fibrosis Trial (Bacillus Calmette Guerin)

Not yet recruiting
  • Urothelial Carcinoma Bladder
  • +2 more
  • Bacillus Calmette Guerin
  • (no location specified)
Jan 18, 2023

Non-muscle-invasive Bladder Cancer Trial in Cairo (BCG, Gemcitabine)

Recruiting
  • Non-muscle-invasive Bladder Cancer
  • Cairo, Egypt
    Mohamed Fawzy Salman
Nov 19, 2022

High-risk NMIBC Trial (SHR-1501)

Recruiting
  • High-risk NMIBC
  • Beijing, Beijing, China
    Peking University First Hospital
Nov 28, 2022

Bladder Cancer Trial in San Antonio (BCG strain of Mycobacterium bovis)

Terminated
Has Results
  • Bladder Cancer
  • BCG strain of Mycobacterium bovis
  • San Antonio, Texas
    MARC - The University of Texas Health Science Center
Oct 17, 2019

Non-muscle Invasive Bladder Cancer, NMIBC, Carcinoma in Situ of Bladder Trial in United States (UGN-301, UGN-201)

Recruiting
  • Non-muscle Invasive Bladder Cancer
  • +5 more
  • Little Rock, Arkansas
  • +7 more
Dec 19, 2022

Interstitial Cystitis, Bladder Pain Syndrome Trial in United States (VNX001, Placebo, Lidocaine)

Not yet recruiting
  • Interstitial Cystitis
  • Bladder Pain Syndrome
  • Escondido, California
  • +7 more
Feb 26, 2023

Can Second Resection for pT1 Bladder Cancer be Avoided After

Recruiting
  • Bladder Cancer Stage I
  • Avoid second resection after initial complete resection
  • Mansoura, Dakahlia, Egypt
    Urology and nephrology center, Mansoura University
Aug 2, 2023

Urge Incontinence, Overactive Bladder, Anesthesia, Local Trial (Alkalinized Lidocaine, Placebo Sodium Chloride 0.9% Inj)

Recruiting
  • Urge Incontinence
  • +5 more
  • Alkalinized Lidocaine
  • Placebo Sodium Chloride 0.9% Inj
  • Herlev, Region Hovedstaden, Denmark
    Kvinde- og Bækkenbundssygdomme, klinik 1
Sep 21, 2022

Bladder Cancer Cell Transitional, Non-Muscle Invasive Bladder Cancer, Bladder Cancer Trial in United States (TSD-001)

Completed
  • Bladder Cancer Cell Transitional
  • +9 more
  • Tucson, Arizona
  • +4 more
Jan 18, 2022

Upper Urinary Tract Carcinoma Trial

Not yet recruiting
  • Upper Urinary Tract Carcinoma
    • (no location specified)
    Feb 7, 2023

    Urothelial Carcinoma Trial in Miami, New Orleans, Rochester (MV-NIS)

    Recruiting
    • Urothelial Carcinoma
    • MV-NIS
    • Miami, Florida
    • +2 more
    Jun 15, 2021

    Superficial Bladder Cancer Trial in United States (ADSTILADRIN)

    Active, not recruiting
    Has Results
    • Superficial Bladder Cancer
    • ADSTILADRIN
    • Gilbert, Arizona
    • +33 more
    Dec 2, 2022

    Bladder Cancer Trial in Denver (Apaziquone, Placebo)

    Terminated
    Has Results
    • Bladder Cancer
    • Denver, Colorado
      The Urology Center of Colorado
    Oct 8, 2021

    Lower Urinary Tract Symptoms, Bladder Carcinoma, BCG Trial in Montreal (Pentosan Polysulfate Na 100Mg Cap, Placebo oral capsule)

    Terminated
    • Lower Urinary Tract Symptoms
    • +2 more
    • Pentosan Polysulfate Na 100Mg Cap
    • Placebo oral capsule
    • Montreal, Quebec, Canada
      Jewish General Hospital
    Feb 16, 2022

    Non-muscle Invasive Bladder Cancer Trial in Shanghai (APL-1202, Epirubicin Hydrochloride)

    Recruiting
    • Non-muscle Invasive Bladder Cancer
    • Shanghai, Shanghai, China
      Fudan University Shanghai Cancer Center
    Feb 21, 2022

    Non-Muscle Invasive Bladder Cancer (NMIBC) Refractory to BCG Trial in Canada, United States (TLD-1433 Bladder infusion and

    Recruiting
    • Non-Muscle Invasive Bladder Cancer (NMIBC) Refractory to BCG
    • TLD-1433 Bladder infusion and Photodynamic Therapy
    • Bala-Cynwyd, Pennsylvania
    • +10 more
    May 6, 2022